TEVA-LISDEXAMFETAMINE

Identification of Teva-Lisdexamfetamine

No description

Google image searchProduct monograph

Active ingredient

lisdexamfetamine dimesylate, 30 MG

DIN: 02545896

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA I)

Company: TEVA CANADA LIMITED

Date: 03-JUN-2024

ATC:

• N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
• N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
• N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
• N06BA12 — LISDEXAMFETAMINE (ATC/DDD)

Reference brand drug: Vyvanse

External Links for Teva-Lisdexamfetamine

Search on Google

• Teva-Lisdexamfetamine side effects
• Teva-Lisdexamfetamine dosage
• lisdexamfetamine dimesylate side effects
• lisdexamfetamine dimesylate dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-lisdexamfetamine photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.